D
Apogee Therapeutics, Inc. APGE
$53.49 $0.280.52% NASDAQ
Recommendation
Prev Close
$53.21
Volume
137,000
Avg Vol (90D)
812,281
Market Cap
$3.12B
Dividend & Yield
--
52-Week Range
$26.20 - $63.50
P/E (TTM)
--
EPS (TTM)
-$4.12
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Why Apogee Therapeutics (APGE) Stock is Moving Today
10/9/2025 - GuruFocus
Why Apogee Therapeutics Stock Triumphed on Thursday
10/9/2025 - Nasdaq News: Markets
Why Apogee Therapeutics Stock Triumphed on Thursday
10/9/2025 - Fool.com Headlines
Apogee Therapeutics' (APGE) "Sell (D-)" Rating Reiterated at Weiss Ratings
10/9/2025 - MarketBeat
Apogee Therapeutics price target lowered to $82 from $87 at BofA
10/9/2025 - TipRanks Financial Blog
Apogee Therapeutics price target lowered by $5 at BofA, here's why
10/9/2025 - The Fly
Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today
10/9/2025 - Stocktwits News Feed
Futures Flat At All Time High, As Silver Tops $50
10/9/2025 - Zero Hedge
Helen of Troy, Ferrari, Apogee Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
10/9/2025 - Benzinga
Apogee Therapeutics 6.95M share Spot Secondary priced at $41.00
10/9/2025 - The Fly
Apogee Therapeutics prices $300M public offering
10/9/2025 - Seeking Alpha - Healthcare
Apogee Therapeutics prices $300M public offering
10/9/2025 - SeekingAlpha.com: All News
Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering
10/9/2025 - GuruFocus
Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering
10/9/2025 - GuruFocus
Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering
10/9/2025 - Globe Newswire
Apogee Therapeutics announces common stock offering, no amount given
10/8/2025 - The Fly
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
10/8/2025 - GuruFocus
Apogee Therapeutics announces common stock offering, no amount given
10/8/2025 - The Fly
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
10/8/2025 - Globe Newswire
Noteworthy Wednesday Option Activity: MRNA, APGE, EU
10/8/2025 - Stock Options Channel
Apogee Therapeutics (NASDAQ:APGE) Trading Up 6.9% - Here's What Happened
10/8/2025 - MarketBeat
Apogee Therapeutics (APGE) Surges Over 14% in Recent Trading
10/8/2025 - GuruFocus
Apogee Therapeutics rises 14.5%
10/8/2025 - TipRanks Financial Blog
Apogee Therapeutics rises 14.5%
10/8/2025 - The Fly
Apogee Therapeutics (NASDAQ:APGE) Insider Sells $203,378.00 in Stock
10/6/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$270.10M
EBIT (TTM)
-$270.83M
Net Income (TTM)
-$237.67M
Balance Sheet
Total Assets (Q)
$657.77M
Total Debt (Q)
$10.85M
Total Liabilities (Q)
$38.37M
Book Value Per Share (Q)
$10.58
Cash Flow
Cash from Operations (TTM)
-$220.74M
Cash from Investing (TTM)
-$8.90M
Cash from Financing (TTM)
$46.54M
Net Change in Cash (TTM)
-$183.11M
Filings
Filing Date
Monday, August 11, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
1.97
7-Day Total Return
35.82%
30-Day Total Return
46.05%
60-Day Total Return
37.14%
90-Day Total Return
44.24%
Year to Date Total Return
13.44%
1-Year Total Return
-0.79%
2-Year Total Return
151.34%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 08, 2025 - $26.20
52-week High
Nov 11, 2024 - $63.50
Valuation
Market Cap
$3.12B - Mid Cap
Enterprise Value
$2.51B
Price/Sales (TTM)
--
Price/Book (Q)
5.03
Dividends and Shares
Shares Outstanding
58.43
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.apogeetherapeutics.com
Phone Number
650 394 5230
Address
Building 17
Suite 102b - 221 Crescent Street
Waltham, MA 02453
Country
United States
Year Founded
2022
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic... more
NASDAQ 10/10/2025 9:58AM Eastern Quotes delayed